2-HOBA: Clinical Trials

9 trials of 2-HOBA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 not yet recruiting, 2 recruiting. 5 Phase 2, 4 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Not yet recruiting 2, Recruiting 2, Completed 1
Not applicable4Completed 4
Phase 11Not yet recruiting 1

Follow 2-HOBA: new trials by email Literature Review of 2-HOBA trials Research Report on 2-HOBA

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension
2-HOBA - Pulmonary Arterial Hypertension
Phase 2Not yet recruitingVanderbilt University Medical Center122027-05-012026-11-10
2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
2-hydroxybenzylamine acetate, Placebo - Alzheimer Disease, Mild Cognitive Impairment
Phase 1 / Phase 2Not yet recruitingMTI Biotech Inc482026-09-012026-09-24
2-HOBA in Systemic Lupus Erythematosus
2-HOBA acetate (2-Hydroxybenzlamine acetate), Placebo - Systemic Lupus Erthematosus (SLE)
Phase 2RecruitingVanderbilt University Medical Center422026-05-152026-05-22
2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
2-Hydroxybenzylamine, Placebo - Familial Hypercholesterolemia
Phase 2RecruitingVanderbilt University Medical Center722024-02-142026-08-07
2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis
2-HOBA, Placebo - Rheumatoid Arthritis
Phase 2CompletedVanderbilt University Medical Center322022-08-092026-04-08
2-HOBA: Multiple Dosing Study in Older Adults
2-HOBA, Placebo - Older Adults
Not applicableCompletedMetabolic Technologies Inc.182018-05-232021-12-14
2-HOBA: Multiple Dosing Study in Healthy Humans
2-HOBA, Placebo - Healthy Volunteers
Not applicableCompletedMetabolic Technologies Inc.182018-05-232019-08-13
Brain Penetrance of 2-HOBA in Humans
2-HOBA - Healthy Adults
Not applicableCompletedMetabolic Technologies Inc.32018-05-232019-02-20
2-HOBA: Initial Evaluation in Humans
2-HOBA - Healthy Volunteers
Not applicableCompletedMetabolic Technologies Inc.182017-08-022018-06-04

Conditions studied

Alzheimer Disease (1)  ·  Arthritis, Rheumatoid (1)  ·  Cognitive Dysfunction (1)  ·  Hyperlipoproteinemia Type II (1)  ·  Hypertension (1)  ·  Hypertension, Pulmonary (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Pulmonary Arterial Hypertension (1)

Sponsors

Metabolic Technologies Inc. (4)  ·  Vanderbilt University Medical Center (4)  ·  MTI Biotech Inc (1)

Countries

United States (8)

Top investigators

John A Rathmacher, PhD (4)  ·  John A. Rathmacher, Ph.D. (1)  ·  MacRae F. Linton, MD (1)  ·  Michelle J Ormseth, MD, MSCI (1)  ·  Michelle Ormseth, MD, MSCI (1)  ·  Patricia Andrews, M.D. (1)  ·  Paul A. Newhouse, M.D. (1)

Results publications

PMID 31907026, PMID 30611293

NIH funding

R44AG055184 (4), P01HL116263 (1), P01HL174442 (1)